BSE Live
Oct 07, 16:01Prev. Close
171.50
Open Price
171.45
Bid Price (Qty.)
168.00 (4)
Offer Price (Qty.)
171.15 (50)
NSE Live
Oct 07, 15:41Prev. Close
171.65
Open Price
171.68
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Key Financial Ratios of Nath Bio-Genes (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 21.72 | 19.81 | 18.51 | -36.00 | 29.29 | |
Diluted EPS (Rs.) | 21.72 | 19.81 | 18.51 | -36.00 | 29.29 | |
Cash EPS (Rs.) | 24.17 | 22.86 | 20.09 | -33.81 | 30.77 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 341.33 | 321.33 | 301.70 | 285.19 | 322.71 | |
Book Value [InclRevalReserve]/Share (Rs.) | 341.33 | 321.33 | 301.70 | 285.19 | 322.71 | |
Dividend / Share(Rs.) | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | |
Revenue from Operations/Share (Rs.) | 190.65 | 175.03 | 158.54 | 146.48 | 161.84 | |
PBDIT/Share (Rs.) | 30.00 | 26.86 | 26.02 | 20.57 | 35.99 | |
PBIT/Share (Rs.) | 28.01 | 25.14 | 24.44 | 18.95 | 34.50 | |
PBT/Share (Rs.) | 23.22 | 22.17 | 19.11 | -33.35 | 29.86 | |
Net Profit/Share (Rs.) | 22.17 | 21.14 | 18.50 | -35.43 | 29.29 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 15.73 | 15.34 | 16.41 | 14.04 | 22.23 | |
PBIT Margin (%) | 14.69 | 14.36 | 15.41 | 12.93 | 21.31 | |
PBT Margin (%) | 12.17 | 12.66 | 12.05 | -22.77 | 18.45 | |
Net Profit Margin (%) | 11.63 | 12.07 | 11.67 | -24.19 | 18.09 | |
Return on Networth / Equity (%) | 6.49 | 6.57 | 6.13 | -12.42 | 9.07 | |
Return on Capital Employed (%) | 8.14 | 7.74 | 8.05 | 6.60 | 10.63 | |
Return on Assets (%) | 4.14 | 4.58 | 4.43 | -9.07 | 7.05 | |
Total Debt/Equity (X) | 0.17 | 0.18 | 0.18 | 0.17 | 0.15 | |
Asset Turnover Ratio (%) | 0.38 | 0.40 | 0.39 | 0.36 | 0.40 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 1.87 | 2.18 | 2.41 | 2.39 | 3.03 | |
Quick Ratio (X) | 0.96 | 1.30 | 1.45 | 1.27 | 1.72 | |
Inventory Turnover Ratio (X) | 1.29 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividend Payout Ratio (NP) (%) | 9.01 | 9.46 | 10.80 | -5.64 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 8.27 | 8.74 | 9.95 | -5.91 | 0.00 | |
Earnings Retention Ratio (%) | 90.99 | 90.54 | 89.20 | 105.64 | 0.00 | |
Cash Earnings Retention Ratio (%) | 91.73 | 91.26 | 90.05 | 105.91 | 0.00 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 300.67 | 363.00 | 165.41 | 494.24 | 635.74 | |
EV/Net Operating Revenue (X) | 0.83 | 1.09 | 0.55 | 1.78 | 2.07 | |
EV/EBITDA (X) | 5.27 | 7.11 | 3.34 | 12.64 | 9.30 | |
MarketCap/Net Operating Revenue (X) | 0.77 | 0.99 | 0.89 | 1.46 | 1.85 | |
Retention Ratios (%) | 90.98 | 90.53 | 89.19 | 105.64 | 0.00 | |
Price/BV (X) | 0.43 | 0.54 | 0.47 | 0.75 | 0.93 | |
Price/Net Operating Revenue | 0.77 | 0.99 | 0.89 | 1.46 | 1.85 | |
Earnings Yield | 0.15 | 0.12 | 0.13 | -0.17 | 0.10 |
14.07.2025
Nath Bio-Genes Standalone June 2025 Net Sales at Rs 280.17 crore, up 14.88% Y-o-Y
14.07.2025
Nath Bio-Genes Consolidated June 2025 Net Sales at Rs 283.70 crore, up 16.33% Y-o-Y
02.05.2025
Nath Bio-Genes Consolidated March 2025 Net Sales at Rs 51.97 crore, up 20.75% Y-o-Y
02.05.2025
Nath Bio-Genes Standalone March 2025 Net Sales at Rs 49.37 crore, up 14.71% Y-o-Y
14.07.2025
Nath Bio-Genes Standalone June 2025 Net Sales at Rs 280.17 crore, up 14.88% Y-o-Y
14.07.2025
Nath Bio-Genes Consolidated June 2025 Net Sales at Rs 283.70 crore, up 16.33% Y-o-Y
02.05.2025
Nath Bio-Genes Consolidated March 2025 Net Sales at Rs 51.97 crore, up 20.75% Y-o-Y
02.05.2025
Nath Bio-Genes Standalone March 2025 Net Sales at Rs 49.37 crore, up 14.71% Y-o-Y